BN

Bhikan Nimba Patil

Active Director Director DIN 08929611
DIN 08929611 First appointment Oct 2020 Primary industry Chemicals and Materials
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2020
Shareholding value •••• Premium profile

About Bhikan Nimba Patil

Data last updated:

Bhikan Nimba Patil is a Director at Decro Pharma Private Limited (since 2020). The company operates in Chemicals and Materials. Decro Pharma Private Limited reported revenue of ₹14.66 Cr (FY 2025).

DIN 08929611
Primary Designation Director
Industry Chemicals and Materials
First Appointment 21 Oct 2020
Oldest Company Age 6 yrs
Largest company Decro Pharma Private Limited · ₹14.66 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Decro Pharma Private Limited U24210GJ2020PTC117562
Director21 Oct 20202020₹14.66 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Decro Pharma Private Limited
Premium access

Shareholding and investment profile for Bhikan Nimba Patil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhikan Nimba Patil

Bhikan Nimba Patil currently holds 1 directorship: Decro Pharma Private Limited (Director, since 21 Oct 2020, revenue ₹14.66 Cr (FY 2025)).

Bhikan Nimba Patil was first appointed on 21 Oct 2020 as Director at Decro Pharma Private Limited.

The current boards of Bhikan Nimba Patil's companies include Arvindbhai Patel (Decro Pharma Private Limited), Hareshbhai Kalabhai Patel (Decro Pharma Private Limited), Narendra Rajdev Pandey (Decro Pharma Private Limited), Rakesh Ambalal Patel (Decro Pharma Private Limited), Sangitaben Rakeshkumar Patel (Decro Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available